Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-19-011903
Filing Date
2019-03-18
Accepted
2019-03-18 17:33:53
Documents
2
Period of Report
2019-03-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6031
2 POWER OF ATTORNEY (PUBLIC): POA FEB 21, 2019 doc1.txt EX-24 3883
  Complete submission text file 0001127602-19-011903.txt   11301
Mailing Address C/O INSPIREMD, INC. 321 COLUMBUS AVENUE BOSTON MA 02116
Business Address
BARER SOL J (Reporting) CIK: 0001247015 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37568 | Film No.: 19689452

Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Issuer) CIK: 0001472091 (see all company filings)

EIN.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations